Diagnosticos da America
R$3.95Change from previous close: −0.75%Absolute change: −R$0.03
At a glance
- Revenue growth
- −27.10%
- 2025 vs 2024
- Net margin
- -10.3%
- 2024: -7.8%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -36.3 | 27.9 | -964 | -29.0 | — |
| Depreciation and amortization | 1,123 | 1,367 | 1,296 | 1,112 | — |
| Capital expenditure | -290 | -538 | -811 | -1,136 | — |
| Investing cash flow | 1,352 | -374 | 979 | -1,600 | — |
| Financing cash flow | -393 | 503 | 285 | 1,771 | — |
| Dividends paid | -5.0 | -10.1 | — | -159 | -220 |
| Share repurchases | — | 0.0 | -108 | 0.0 | — |
| Debt issued | 4,350 | 1,710 | 3,300 | 6,005 | — |
| Debt repaid | -4,185 | -2,075 | -3,971 | -2,298 | — |
| Net change in cash | 922 | 158 | 300 | 142 | — |
| Free cash flow | -327 | -511 | -1,775 | -1,165 | — |